EquitAI LogoEquitAI
$288.50
-1.65%
CRL

CRL

Charles River Laboratories Inte

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
6/10
Quality
3/10
Growth
3/10
Strength
3/10
Dividend
1/10
Price Trend
Upwards
Momentum
Stretched
Balance Sheet
Moderate
Earnings
Stable
Dividend Yield
0.00%
Market Cap
$13.90B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Charles River Laboratories provides essential products and preclinical services to help pharmaceutical and biotechnology companies accelerate their research and drug development efforts. Their core offerings include research animal models, safety assessment testing, and laboratory support services. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...